nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.0425	0.147	CbGpPWpGaD
Icosapent ethyl—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.0331	0.0472	CcSEcCtD
Icosapent ethyl—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.0314	0.0448	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.0271	0.0934	CbGpPWpGaD
Icosapent ethyl—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0268	0.0382	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.0255	0.0878	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.025	0.0863	CbGpPWpGaD
Icosapent ethyl—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.0244	0.0347	CcSEcCtD
Icosapent ethyl—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0213	0.0304	CcSEcCtD
Icosapent ethyl—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.0204	0.029	CcSEcCtD
Icosapent ethyl—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0282	CcSEcCtD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.019	0.0654	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOE—amyotrophic lateral sclerosis	0.0187	0.0646	CbGpPWpGaD
Icosapent ethyl—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0183	0.026	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.0175	0.0602	CbGpPWpGaD
Icosapent ethyl—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.017	0.0242	CcSEcCtD
Icosapent ethyl—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0239	CcSEcCtD
Icosapent ethyl—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0237	CcSEcCtD
Icosapent ethyl—Polyp—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0234	CcSEcCtD
Icosapent ethyl—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0213	CcSEcCtD
Icosapent ethyl—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0209	CcSEcCtD
Icosapent ethyl—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0198	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.0132	0.0456	CbGpPWpGaD
Icosapent ethyl—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0177	CcSEcCtD
Icosapent ethyl—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0156	CcSEcCtD
Icosapent ethyl—Cataract—Riluzole—amyotrophic lateral sclerosis	0.0105	0.015	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0103	0.0354	CbGpPWpGaD
Icosapent ethyl—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0144	CcSEcCtD
Icosapent ethyl—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00976	0.0139	CcSEcCtD
Icosapent ethyl—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00948	0.0135	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00938	0.0324	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00936	0.0323	CbGpPWpGaD
Icosapent ethyl—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00903	0.0129	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00872	0.0301	CbGpPWpGaD
Icosapent ethyl—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0085	0.0121	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.0082	0.0283	CbGpPWpGaD
Icosapent ethyl—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00807	0.0115	CcSEcCtD
Icosapent ethyl—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00772	0.011	CcSEcCtD
Icosapent ethyl—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0106	CcSEcCtD
Icosapent ethyl—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00714	0.0102	CcSEcCtD
Icosapent ethyl—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00714	0.0102	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0069	0.00983	CcSEcCtD
Icosapent ethyl—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00687	0.00979	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00653	0.0225	CbGpPWpGaD
Icosapent ethyl—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00653	0.00931	CcSEcCtD
Icosapent ethyl—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00915	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00912	CcSEcCtD
Icosapent ethyl—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00631	0.00899	CcSEcCtD
Icosapent ethyl—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00627	0.00893	CcSEcCtD
Icosapent ethyl—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00627	0.00893	CcSEcCtD
Icosapent ethyl—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00627	0.00893	CcSEcCtD
Icosapent ethyl—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00615	0.00876	CcSEcCtD
Icosapent ethyl—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00611	0.0087	CcSEcCtD
Icosapent ethyl—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00603	0.00859	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00577	0.00823	CcSEcCtD
Icosapent ethyl—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00801	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00562	0.0194	CbGpPWpGaD
Icosapent ethyl—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00797	CcSEcCtD
Icosapent ethyl—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00797	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00551	0.00785	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00781	CcSEcCtD
Icosapent ethyl—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00536	0.00764	CcSEcCtD
Icosapent ethyl—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00527	0.00751	CcSEcCtD
Icosapent ethyl—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00747	CcSEcCtD
Icosapent ethyl—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00717	CcSEcCtD
Icosapent ethyl—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00498	0.0071	CcSEcCtD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—amyotrophic lateral sclerosis	0.00479	0.56	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00457	0.0158	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00457	0.0158	CbGpPWpGaD
Icosapent ethyl—Chills—Riluzole—amyotrophic lateral sclerosis	0.0045	0.00642	CcSEcCtD
Icosapent ethyl—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00639	CcSEcCtD
Icosapent ethyl—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00632	CcSEcCtD
Icosapent ethyl—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00623	CcSEcCtD
Icosapent ethyl—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0061	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00426	0.0147	CbGpPWpGaD
Icosapent ethyl—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00602	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00418	0.0144	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00405	0.00578	CcSEcCtD
Icosapent ethyl—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00561	CcSEcCtD
Icosapent ethyl—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00559	CcSEcCtD
Icosapent ethyl—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00558	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00388	0.0134	CbGpPWpGaD
Icosapent ethyl—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00547	CcSEcCtD
Icosapent ethyl—Cough—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00543	CcSEcCtD
Icosapent ethyl—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00537	CcSEcCtD
Icosapent ethyl—Icosapent—PTGS2—amyotrophic lateral sclerosis	0.00376	0.44	CrCbGaD
Icosapent ethyl—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0053	CcSEcCtD
Icosapent ethyl—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0053	CcSEcCtD
Icosapent ethyl—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0053	CcSEcCtD
Icosapent ethyl—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00524	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00365	0.0126	CbGpPWpGaD
Icosapent ethyl—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00518	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00508	CcSEcCtD
Icosapent ethyl—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00508	CcSEcCtD
Icosapent ethyl—Infection—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00505	CcSEcCtD
Icosapent ethyl—Shock—Riluzole—amyotrophic lateral sclerosis	0.00351	0.005	CcSEcCtD
Icosapent ethyl—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00496	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00491	CcSEcCtD
Icosapent ethyl—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00484	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—DAO—amyotrophic lateral sclerosis	0.0033	0.0114	CbGpPWpGaD
Icosapent ethyl—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00463	CcSEcCtD
Icosapent ethyl—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0046	CcSEcCtD
Icosapent ethyl—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00453	CcSEcCtD
Icosapent ethyl—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00447	CcSEcCtD
Icosapent ethyl—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00442	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00439	CcSEcCtD
Icosapent ethyl—Pain—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00434	CcSEcCtD
Icosapent ethyl—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00434	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00419	CcSEcCtD
Icosapent ethyl—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00402	CcSEcCtD
Icosapent ethyl—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00365	CcSEcCtD
Icosapent ethyl—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00359	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.0025	0.00863	CbGpPWpGaD
Icosapent ethyl—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00336	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00231	0.00797	CbGpPWpGaD
Icosapent ethyl—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00323	CcSEcCtD
Icosapent ethyl—Rash—Riluzole—amyotrophic lateral sclerosis	0.00225	0.0032	CcSEcCtD
Icosapent ethyl—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00225	0.0032	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.0021	0.00726	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.0019	0.00654	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00173	0.00597	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00119	0.00409	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00102	0.00352	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000937	0.00323	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000771	0.00266	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000528	0.00182	CbGpPWpGaD
